NAFDAC warns Nigerians against taking `Maishayi’ tea - Welcome to Sodeeqloaded Welcome to Sodeeqloaded: NAFDAC warns Nigerians against taking `Maishayi’ tea

Pages

Featured Featured
how-to-use-your-android-device-as
How To Use Your Android Device as Keyboard and Mouse
dent-free-data
Sharing of Apk Files on Whatsapp Made Easier
9mobile-special-offer
9mobile Special Data, Get 1GB Data for N200 and 5GB for N1000
mtn-double-data-cheat
New Method To Activate MTN 100% Double Data Bonus Via IMEI Tweaking


Monday, February 24, 2020

NAFDAC warns Nigerians against taking `Maishayi’ tea

The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians to be cautious when taking tea popularly known as `Maishayi’ from vendors.

Prof. Mojisola Adeyeye, NAFDAC Director-General gave the warning in an interview with the News Agency of Nigeria (NAN) on Monday in Abuja.

Adeyeye said that the warning became necessary following information the agency received that Maishayi now mix intoxicating drugs in the tea prepared for customers.

She mentioned intoxicating drugs such as tramadol, Vieteling, Marijuana and others, adding that people could lose their lives after taking tea mixed with such drugs.


“In the US, lots of people are dying because of these medicines. How can such medicines mix with palm wine in the name of getting high in Nigeria?

“There are some medicines you cannot take if you have cardiovascular problem,” she said.

The director-general said that the agency was working toward collaborating with the National Institute for Pharmaceutical Research and Development (NIPRD) to check for quality medicine in orthodox and herbal.

According to her, the idea is necessary since NIPRD specialises on research, and the purpose is to safeguard the health of the nation.



source https://www.ladunliadinews.com/2020/02/nafdac-warns-nigerians-against-taking.html

Copy the link below and Share with your Friends:

Download Our Official Android App on Google Playstore HERE
OR
Download from another source HERE



No comments:

Post a Comment